Abbott Laboratories Pre-Paid Expenses 2010-2025 | ABT
Abbott Laboratories pre-paid expenses from 2010 to 2025. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
- Abbott Laboratories pre-paid expenses for the quarter ending March 31, 2025 were $2.343B, a 2.18% increase year-over-year.
- Abbott Laboratories pre-paid expenses for 2024 were $2.57B, a 13.92% increase from 2023.
- Abbott Laboratories pre-paid expenses for 2023 were $2.256B, a 15.28% decline from 2022.
- Abbott Laboratories pre-paid expenses for 2022 were $2.663B, a 13.51% increase from 2021.
| Abbott Laboratories Annual Pre-Paid Expenses (Millions of US $) |
|
|---|---|
| 2024 | $2,570 |
| 2023 | $2,256 |
| 2022 | $2,663 |
| 2021 | $2,346 |
| 2020 | $1,867 |
| 2019 | $1,786 |
| 2018 | $1,568 |
| 2017 | $1,667 |
| 2016 | $1,806 |
| 2015 | $1,908 |
| 2014 | $1,975 |
| 2013 | $1,504 |
| 2012 | $1,757 |
| 2011 | $2,003 |
| 2010 | $1,545 |
| 2009 | $1,211 |
| Abbott Laboratories Quarterly Pre-Paid Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $2,343 |
| 2024-12-31 | $2,570 |
| 2024-09-30 | $2,150 |
| 2024-06-30 | $2,232 |
| 2024-03-31 | $2,293 |
| 2023-12-31 | $2,256 |
| 2023-09-30 | $2,468 |
| 2023-06-30 | $2,307 |
| 2023-03-31 | $2,152 |
| 2022-12-31 | $2,663 |
| 2022-09-30 | $2,796 |
| 2022-06-30 | $2,568 |
| 2022-03-31 | $2,401 |
| 2021-12-31 | $2,346 |
| 2021-09-30 | $2,134 |
| 2021-06-30 | $2,131 |
| 2021-03-31 | $1,962 |
| 2020-12-31 | $1,867 |
| 2020-09-30 | $1,858 |
| 2020-06-30 | $1,842 |
| 2020-03-31 | $1,970 |
| 2019-12-31 | $1,786 |
| 2019-09-30 | $1,942 |
| 2019-06-30 | $1,919 |
| 2019-03-31 | $1,718 |
| 2018-12-31 | $1,568 |
| 2018-09-30 | $1,582 |
| 2018-06-30 | $1,935 |
| 2018-03-31 | $1,720 |
| 2017-12-31 | $1,667 |
| 2017-09-30 | $1,895 |
| 2017-06-30 | $1,912 |
| 2017-03-31 | $1,964 |
| 2016-12-31 | $1,806 |
| 2016-09-30 | $1,986 |
| 2016-06-30 | $2,104 |
| 2016-03-31 | $2,157 |
| 2015-12-31 | $1,908 |
| 2015-09-30 | $3,523 |
| 2015-06-30 | $3,573 |
| 2015-03-31 | $3,859 |
| 2014-12-31 | $1,975 |
| 2014-09-30 | $4,173 |
| 2014-06-30 | $4,065 |
| 2014-03-31 | $3,977 |
| 2013-12-31 | $1,504 |
| 2013-09-30 | $3,918 |
| 2013-06-30 | $3,240 |
| 2013-03-31 | $3,414 |
| 2012-12-31 | $1,757 |
| 2012-09-30 | $4,997 |
| 2012-06-30 | $4,969 |
| 2012-03-31 | $4,866 |
| 2011-12-31 | $2,003 |
| 2011-09-30 | $4,805 |
| 2011-06-30 | $4,726 |
| 2011-03-31 | $4,710 |
| 2010-12-31 | $1,545 |
| 2010-09-30 | $4,168 |
| 2010-06-30 | $4,165 |
| 2010-03-31 | $4,067 |
| 2009-12-31 | $1,211 |
| 2009-09-30 | $3,824 |
| 2009-06-30 | $3,767 |
| 2009-03-31 | $3,918 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $231.381B | $41.950B |
| Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boston Scientific (BSX) | United States | $149.868B | 37.52 |
| Stryker (SYK) | United States | $143.347B | 29.97 |
| EssilorLuxottica (ESLOY) | France | $128.152B | 0.00 |
| Medtronic (MDT) | Ireland | $110.735B | 15.70 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.273B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.835B | 26.69 |
| ResMed (RMD) | United States | $37.196B | 27.94 |
| Agilent Technologies (A) | United States | $32.827B | 21.40 |
| GE HealthCare Technologies (GEHC) | United States | $32.638B | 15.50 |
| Terumo (TRUMY) | Japan | $26.398B | 34.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.463B | 15.06 |
| Insulet (PODD) | United States | $21.334B | 83.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.048B | 11.59 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.627B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.442B | 22.42 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $4.123B | 18.42 |
| Perrigo (PRGO) | Ireland | $3.643B | 9.23 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.415B | 15.55 |
| Envista Holdings (NVST) | United States | $3.202B | 26.61 |
| ICU Medical (ICUI) | United States | $3.144B | 23.18 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| LeMaitre Vascular (LMAT) | United States | $1.848B | 41.30 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.324B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.132B | 11.49 |
| Neogen (NEOG) | United States | $1.072B | 13.72 |
| Green Thumb Industries (GTBIF) | United States | $1.042B | 23.43 |
| BioLife Solutions (BLFS) | United States | $1.008B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.37 |
| InMode (INMD) | Israel | $0.839B | 8.46 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| CeriBell (CBLL) | United States | $0.647B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Owens & Minor (OMI) | United States | $0.567B | 4.71 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.525B | 0.00 |
| Valneva SE (VALN) | France | $0.478B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.377B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.362B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.319B | 11.74 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.288B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.262B | 22.07 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.13 |
| Sanara MedTech (SMTI) | United States | $0.242B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 68.00 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.217B | 6.09 |
| Cresco Labs (CRLBF) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.206B | 54.55 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.19 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Organigram Global (OGI) | Canada | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.40 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.34 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.053B | 71.43 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |